Results
1 -
7 of
7
(Click
here to explore results)
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 2 Phytocannabinoids Versus Endocannabinoids. A Modern View of the Endocannabinoid System. Javier Fernández-Ruiz, Onintza Sagredo, Eva de Lago
, 2021
, Pages 10-47
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 10 Small-molecule Inhibitors of Endocannabinoid Transport and Trafficking. Inés Reynoso Moreno, Jürg Gertsch
, 2021
, Pages 414-450
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Subject Index
, 2021
, Pages 451-457
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 4 Natural Compounds and Synthetic Drugs to Target Type-2 Cannabinoid (CB2) Receptor. Wolfgang Guba, Marc Nazaré, Uwe Grether
, 2021
, Pages 89-167
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 5 Natural and Synthetic Cannabinoids Targeting Non-CB1, Non-CB2 G Protein-coupled Receptors. Paula Morales, Israa H. Isawi, Patricia H. Reggio
, 2021
, Pages 168-200
- Vitamin E: Chemistry and Nutritional Benefits, CHAPTER 7 Novel Functions of Vitamin E Nicotinate. Y. J. Suzuki, L. Marcocci, K. R. Duncan, D. I. Suzuki, N. V. Shults
, 2019
, Pages 88-97
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 3 Natural Compounds and Synthetic Drugs to Target Type-1 Cannabinoid (CB1) Receptor. Christos Iliopoulos-Tsoutsouvas, Markos-Orestis Georgiadis, Lipin Ji, Spyros P. Nikas, Alexandros Makriyannis
, 2021
, Pages 48-88